FORMULATION DEVELOPMENT OF SUSTAINED RELEASE INTRA-ARTICULAR INJECTION OF ANALGESIC DRUG

  • Reshma Mirajkar Department of Pharmaceutics, AISSMS College of Pharmacy, Near RTO, Kennedy Road, Pune 411001, Maharashtra, India
  • Rutuja Kurkute Department of Pharmaceutics, AISSMS College of Pharmacy, Near RTO, Kennedy Road, Pune 411001, Maharashtra, India
  • Ashwini Madgulkar Department of Pharmaceutics, AISSMS College of Pharmacy, Near RTO, Kennedy Road, Pune 411001, Maharashtra, India

Abstract

The purpose of this study was to formulate and evaluate Parenteral Intraarticular Sustained-Release Formulation of an analgesic drug using the technology of in situ forming gel, based on temperature change mechanism in order to reduce the frequency of dosing and increase patient compliance in the treatment of knee pain. The formulation was optimized, prepared, filled aseptically, sterilized and evaluated for prerequisites of parenteral and other parameters like gelation temperature, gel strength, viscosity, drug content, in vitro and in vivo studies and stability studies. It was prepared using cold method and optimized by 32 factorial design, comprising of drug, Pluronic F127, HPMC K 100M and HPMC K4M was found to be clear, colorless, isotonic, sterile, pH as 6.8-7, viscosity of 1800 cps, syringeable through 18 gauze needle, forming a stable in-situ gel at knee joint temperature having gel strength of 43.80 gm/cm showing a drug release of 95.88 % in phosphate buffer pH 7.4 at 120hrs. The sterile formulation packed in transparent ampoule was found to the stable with most suitable storage condition at the refrigerator temperature. Thus a biocompatible, stable parenteral formulation was developed which can be an alternative and convenient approach to the patients that require frequent parenteral administration, reducing the frequency of dosing and ultimately increasing patient compliance and comfort.

Keywords: Tramadol HCL, In situ gel, Pluronic F127, intra-articular

Downloads

Download data is not yet available.

Author Biographies

Reshma Mirajkar, Department of Pharmaceutics, AISSMS College of Pharmacy, Near RTO, Kennedy Road, Pune 411001, Maharashtra, India

Department of Pharmaceutics, AISSMS College of Pharmacy, Near RTO, Kennedy Road, Pune 411001, Maharashtra, India

Rutuja Kurkute, Department of Pharmaceutics, AISSMS College of Pharmacy, Near RTO, Kennedy Road, Pune 411001, Maharashtra, India

Department of Pharmaceutics, AISSMS College of Pharmacy, Near RTO, Kennedy Road, Pune 411001, Maharashtra, India

Ashwini Madgulkar, Department of Pharmaceutics, AISSMS College of Pharmacy, Near RTO, Kennedy Road, Pune 411001, Maharashtra, India

Department of Pharmaceutics, AISSMS College of Pharmacy, Near RTO, Kennedy Road, Pune 411001, Maharashtra, India

References

1. [Internet]. Samples.jbpub.com. 2018 [cited 1 June 2018]. Available from: http://samples.jbpub.com/9781449698843/9781449698843_CH01_Print.pdf
2. Dong RK, Gi Young Park. Intraarticular Injections for the Treatment of Osteoarthritis. Focus on the Clinical Use of Several Regimens. INTECH Open Access Publisher; 2012. P. 67-100.
3. Egemen A, Hayrettin K, Isik A, Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis, World journal of orthopaedics, 2014,
4. Patel HR, Patel RP, Patel MM. Poloxamers: A pharmaceutical excipients with therapeutic behaviors, International Journal of PharmTech Research, 2009; 1(2):299-303
5. Zilretta Uses, Side Effects & Warnings - Drugs.com [Internet]. Drugs.com. 2018 [cited 14 June 2018]. Available from: https://www.drugs.com/mtm/zilretta-injection.html
6. Diana Ernst R. Durolane Now Available to Treat Knee Osteoarthritis Pain [Internet]. MPR. 2018 [cited 14 June 2018]. Available from: https://www.empr.com/news/durolane-knee-osteoarthritis-hyaluronic-acid-single-injection/article/748533/
7. Ranga S, Jaimini M, Sharma S, Chauhan B, Kumar A., A review on design of experiments (DOE), Review article. International Journal of Pharmaceutical and chemical sciences, 2014; 3(1):26-224.
8. Abashzadeh S.,Dinarvand R.,Sharifzadeh M.,Hassanzadeh G, Amini M, Atyabi F. Formulation and evaluation of an in situ gel forming system for controlled delivery of triptorelin acetate. European journal of pharmaceutical sciences.2011; 4(4):514-521.
9. Pachpute D, Patil D, Chaudhari P. Formulation development and evaluation of in situ-nasal gel of levodopa. International Journal of pharmaceutical sciences. 2014; 4(5):449-453.
10. Jadhav P, Jadhav N, Hosmani A, Patil S.Development and evalution of in-situ thermoresponsive nasal gel system for Nardostachys jatamansi,Schlolars research library der pharmacia letter.2013; 5(2):113-125.
11. Sindhu SK, Gowda DV, Formulation and Evaluation of Injectable In-Situ Gelling Matrix System for Controlled Drug Release, Indian Journal of Advances in Chemical Science, 2014; 2:89-92.
12. Nikam K, Pawar M, Jadhav S, Bairagi V. Novel trends in parenteral drug delivery system, Review. International Journal of pharmacy and technology. 2013; 5(2):2549-2577.
13. Jun L, Bouchu W, Yazhou W. Thermo-sensitive polymers for controlled release drug delivery system. International Journal of Pharmacology, 2006; 2(5):513-519.
14. Chen J, Zhou R, Li L, Li B, Zhang X, Su J. Mechanical, Rheological and Release Behaviors of a Poloxamer 407/ Poloxamer 188/Carbopol 940 Thermosensitive Composite Hydrogel. Molecules. 2013; 18(10):12415-12425.
15. Princely S. Design and evaluation of controlled release gentamycin incorporated gelatine alginate matrices for wound management. Scholars Research Library, 2015; 7 (1):145-153.
16. Indian Pharmacopoeia 2016. The Government of India ministry of health and family welfare. Published by The Indian Pharmacopoeia Commission. Ghaziabad, 7th ed. Vol-I. 59-66.
17. World Health Organization. Test for sterility. Document QAS/11.413. 2012, 1-9
18. Erfani Jabarian L, Rouini M, Atyabi F, Foroumadi A, Nassiri S, Dinarvand R. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide. European Journal of Pharmaceutical Sciences, 2013; 48(1-2):87-96.
19. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles, European Journal of Pharmaceutical science, 2001; 13:123-133.
20. Alam A. et al. Formulation and Evaluation of Pharmaceutically Equivalent Parenteral Depot Suspension of Methyl Prednisolone Acetate. Indian J Pharm Sci. 2009; 71(1):30–34.
21. J. Mulhbacher, P. Ispas-Szabo, M.A. Mateescu. Cross-Linked High Amylose Starch derivatives for Drug Release, Swelling Properties, and Mechanistic Study. Int. J. Pharm. 2004; 231-8.
22. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. Stability testing of new drug substances and products Q1A (R2). 4th version, 200.
23. Mazzo DJ: The ICH stability guidelines, Interpharm press, Inc:p, 2003, 1-30.
Statistics
33 Views | 102 Downloads
How to Cite
Mirajkar, R., Kurkute, R., & Madgulkar, A. (2018). FORMULATION DEVELOPMENT OF SUSTAINED RELEASE INTRA-ARTICULAR INJECTION OF ANALGESIC DRUG. Journal of Drug Delivery and Therapeutics, 8(4), 209-217. https://doi.org/10.22270/jddt.v8i4.1770